Avishai Shemesh

7PUBLICATIONS
31CO-AUTHORS
Micro- and nanosystemsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Microbial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function.

Vincent Allain, Allison G Rothrock, Pierre-Louis Bernard

|Nov 02, 2025
FcɛR1γ-based activating chimeric antigen receptor enhanced natural killer cell function against HLA-E+ cells.

Lewis L Lanier, John R Greenland, Frank Momburg

|Mar 12, 2025
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Alberto J Millan, Vincent Allain, Indrani Nayak

|Feb 13, 2025
CITE-Seq Analysis Reveals a Differential Natural Killer Cell SPON2 Expression in Cardiovascular Disease Patients Impacted by Human-Cytomegalovirus Serostatus and Diabetes.

Sujit Silas Armstrong, Daniel G Chen, Sunil Kumar

|Jul 19, 2024
Spleen Tyrosine Kinase (SYK) negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Alberto J Millan, Vincent Allain, Indrani Nayak

|Sep 06, 2022
Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression.

Avishai Shemesh, Yapeng Su, Daniel R Calabrese

Pageof 2

Frequent Collaborators

6 joint publications

Lewis L Lanier

3 joint publications

Justin Eyquem

3 joint publications

Oscar A Aguilar

3 joint publications

Janice S Arakawa-Hoyt